SCHEMBL6830174

SCHEMBL6830174

O=[N+]([O-])c1ccc2nc(-c3ccc(P(=O)(O)O)o3)[nH]c2c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHEK1 O14757 1/20 0.60
LIMK1 P53667 1/20 0.60
CDK5 Q00535 1/20 0.60
CLK4 Q9HAZ1 1/20 0.60
NPC1 O15118 7/20 0.57
MAPT P10636 7/20 0.57
RAB9A P51151 7/20 0.57
HTT P42858 4/20 0.57
CASP3 P42574 2/20 0.57
SENP8 Q96LD8 2/20 0.57
SENP7 Q9BQF6 2/20 0.57
SENP6 Q9GZR1 2/20 0.57
MMP2 P08253 1/20 0.57
MMP9 P14780 1/20 0.57
MMP8 P22894 1/20 0.57
MMP13 P45452 1/20 0.57
NPBWR1 P48145 13/20 0.56
SMN1; SMN2 Q16637 5/20 0.55
MEN1 O00255 4/20 0.54
KMT2A Q03164 4/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6830169 0.91 MMP2 (0.48) CHEK1LIMK1CDK5CLK4NPC1
SCHEMBL6831938 0.81 ALDH1A1 (0.48) NPC1MAPTRAB9ANPBWR1SMN1; SMN2
SCHEMBL6830171 0.81 MMP13 (0.48) NPC1MAPTRAB9AMMP2MMP9
SCHEMBL6826831 0.81 MAPT (0.48) NPC1MAPTRAB9AHTTCASP3
SCHEMBL6830874 0.81 ALOX5 (0.53) NPC1MAPTRAB9AHTTSMN1; SMN2
SCHEMBL6830048 0.81 AMY1A (0.47) NPC1MAPTRAB9ASMN1; SMN2ALDH1A1
SCHEMBL1171437 0.79 NPC1 (0.82) CHEK1LIMK1CDK5CLK4NPC1
SCHEMBL6826910 0.79 NPBWR1 (0.51) NPBWR1
SCHEMBL6829917 0.79 METAP2 (0.47) CHEK1LIMK1CDK5CLK4NPC1
SCHEMBL6829765 0.78 MMP2 (0.56) NPC1RAB9ACASP3SENP8SENP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1402895-A1 Benzimidazole inhibitors of fructose 1,6-biphosphatase Metabasis Therapeutics, Inc. (US) 2004-03-31 EP disclosed
EP-0970095-B1 NOVEL BENZIMIDAZOLE INHIBITORS OF FRUCTOSE-1,6-BISPHOSPHATASE METABASIS THERAPEUTICS INC (US) 2003-10-29 EP disclosed
US-6399782-B1 ANTIDIABETIC AGENTS METABASIS THERAPEUTICS, INC. 2002-06-04 US disclosed
US-6110903-A INHIBITORS OF FRUCTOSE-1,6-BISPHOSPHATASE AT THE AMP SITE; ADMINISTERING TO TREAT DIABETES AND INHIBIT GLUCONEOGENESIS; 5-FLUORO-7-BROMO-1-ISOBUTYL-2-(2-PHOSPHONO-5-FURANYL) BENZIMIDAZOLE, FOR EXAMPLE SANKYO COMPANY LTD. (JP) 2000-08-29 US disclosed
EP-0970095-A1 NOVEL BENZIMIDAZOLE INHIBITORS OF FRUCTOSE-1,6-BISPHOSPHATASE Metabasis Therapeutics, Inc. (US) 2000-01-12 EP disclosed
WO-1998039343-A9 NOVEL BENZIMIDAZOLE INHIBITORS OF FRUCTOSE-1,6-BISPHOSPHATASE 1999-01-21 WO disclosed
WO-1998039343-A1 NOVEL BENZIMIDAZOLE INHIBITORS OF FRUCTOSE-1,6-BISPHOSPHATASE METABASIS THERAPEUTICS, INC. (US) 1998-09-11 WO disclosed